TRIEU VUONG (CEO and Chairman of the Board) purchased 0.3% of their position (255K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $11.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 6/25/2026ACC: 0001493152-26-029997
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+255K
Net shares
Net buyer
$11.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
255K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+65K
Price / share
$0.04
Trade value
$2.92K
% of position
0.1%
6/22/2026
93.63M→93.69M
Common Stock
Direct
Shares
+75K
Price / share
$0.04
Trade value
$3.38K
% of position
0.1%
6/23/2026
93.69M→93.77M
Common Stock
Direct
Shares
+115K
Price / share
$0.04
Trade value
$5.17K
% of position
0.1%
6/24/2026
93.77M→93.88M
Total
Net shares
+255K
Net value
$11.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | P · Purchase | +65K | $0.04 | $2.92K | 0.1% | 93.63M | 93.69M |
| Common Stock Direct | 6/23/2026 | P · Purchase | +75K | $0.04 | $3.38K | 0.1% | 93.69M | 93.77M |
| Common Stock Direct | 6/24/2026 | P · Purchase | +115K | $0.04 | $5.17K | 0.1% | 93.77M | 93.88M |
| Total | +255K | $11.47K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned6.87M
Common Stock
IndirectShares owned16.78M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.87M | Indirect |
| Common Stock | 16.78M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported